tiprankstipranks
Trending News
More News >
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Income Statement

Compare
320 Followers

Silence Therapeutics Income Statement

Last quarter (Q3 2025), Silence Therapeutics's total revenue was £159.00K, a decrease of -86.08% from the same quarter last year. In Q3, Silence Therapeutics's net income was £-20.96M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 43.26M£ 25.38M£ 21.66M£ 12.41M£ 5.48M
Gross Profit
£ 31.45M£ 15.06M£ 8.19M£ 4.96M£ 1.72M
Operating Expenses
£ 94.77M£ 64.66M£ 69.23M£ 50.77M£ 37.56M
Depreciation and Amortization
£ 593.00K£ 498.00K£ 596.00K£ 427.00K£ 496.00K
EBITDA
£ -48.99M£ -49.78M£ -60.44M£ -45.42M£ -35.53M
Operating Income
£ -63.32M£ -49.60M£ -61.04M£ -45.81M£ -35.85M
Other Income/Expenses
£ 18.86M£ -706.00K£ 11.39M£ -42.00K£ -194.00K
Pretax Income
£ -44.46M£ -50.31M£ -49.65M£ -45.86M£ -36.04M
Net Income
£ -45.31M£ -43.27M£ -50.33M£ -39.41M£ -32.55M
Per Share Metrics
Basic EPS
£ -2.37£ -3.48£ -3.81£ -1.36£ -1.12
Diluted EPS
£ -2.37£ -3.48£ -3.81£ -1.36£ -1.12
Weighted Average Shares Outstanding
15.42M 12.36M 10.73M 29.65M 27.26M
Weighted Average Shares Outstanding (Diluted)
15.42M 12.36M 10.73M 29.65M 27.26M
Currency in GBP

Silence Therapeutics Earnings and Revenue History